Marker Therapeutics Stock Forecast - Day Median Price
| MRKR Stock | USD 4.40 0.03 0.68% |
Marker Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Marker Therapeutics stock prices and determine the direction of Marker Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Marker Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Marker Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Marker Therapeutics' systematic risk associated with finding meaningful patterns of Marker Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Marker Therapeutics to cross-verify your projections. Marker |
Most investors in Marker Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Marker Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Marker Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Median Price is the statistical median of an asset price for a given trading period.| Previous Day Median Price | Day Median Price | Trend |
| 4.32 | 4.47 |
| Check Marker Therapeutics Volatility | Backtest Marker Therapeutics | Information Ratio |
Marker Therapeutics Trading Date Momentum
| On April 24 2024 Marker Therapeutics was traded for 4.40 at the closing time. The top price for the day was 4.59 and the lowest listed price was 4.36 . The trading volume for the day was 10 K. The trading history from April 24, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.68% . |
The median price is the midpoint of the trading periods range.
| Compare Marker Therapeutics to competition |
Other Forecasting Options for Marker Therapeutics
For every potential investor in Marker, whether a beginner or expert, Marker Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Marker Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Marker. Basic forecasting techniques help filter out the noise by identifying Marker Therapeutics' price trends.View Marker Therapeutics Related Equities
| Risk & Return | Correlation |
Marker Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Marker Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Marker Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Marker Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Marker Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Marker Therapeutics shares will generate the highest return on investment. By undertsting and applying Marker Therapeutics stock market strength indicators, traders can identify Marker Therapeutics entry and exit signals to maximize returns.
Marker Therapeutics Risk Indicators
The analysis of Marker Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Marker Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting marker stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.03 | |||
| Semi Deviation | 3.93 | |||
| Standard Deviation | 3.78 | |||
| Variance | 14.26 | |||
| Downside Variance | 16.67 | |||
| Semi Variance | 15.48 | |||
| Expected Short fall | (3.05) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Marker Therapeutics to cross-verify your projections. To learn how to invest in Marker Stock, please use our How to Invest in Marker Therapeutics guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Marker Stock analysis
When running Marker Therapeutics' price analysis, check to measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is Marker Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Marker Therapeutics. If investors know Marker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Marker Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.59) | Revenue Per Share 0.376 | Quarterly Revenue Growth 0.392 | Return On Assets (0.35) | Return On Equity (0.83) |
The market value of Marker Therapeutics is measured differently than its book value, which is the value of Marker that is recorded on the company's balance sheet. Investors also form their own opinion of Marker Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Marker Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Marker Therapeutics' market value can be influenced by many factors that don't directly affect Marker Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Marker Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Marker Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Marker Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.